‘HOT’ stock: ResMed (RMD)
Raymond Chan, Private Adviser & Head of Asian Desk at Morgans, explains why Morgans regards ResMed (RMD) as a BUY.
Daily News for Informed Investors
Raymond Chan, Private Adviser & Head of Asian Desk at Morgans, explains why Morgans regards ResMed (RMD) as a BUY.
Here are three stocks, two with world-leading proprietary software and one with a growing specialisation in providing its clients with the capability and capacity to…
For the week ending Friday 1 May 2026, FNArena recorded nine upgrades and 10 downgrades from the seven brokers monitored daily across ASX-listed companies.
Switzer TV aired its 4 May 2026 edition on the eve of the RBA’s May rate decision, with four expert guests joining Peter Switzer to…
With next week’s Budget threatening to overshadow even the RBA’s rate decision, Treasurer Chalmers is expected to offer a golden handshake to many public servants....
With all the talk about the May 12 budget containing significant tax reform, Anthony Albanese sounded very sensitive when confronted about one big reform his...
Australians are getting a new battery for their home energy at record rates. But do the savings really add up?
39 bedrooms, 59 bathrooms, a Jeff Koons sculpture by the pool, and sits on almost eight acres of LA real estate.
Stocks were largely up on Wall Street for Friday’s trade, and it followed our local market snapping our worst run of outs — eight days…
If you care about particular issues – from climate change to weapons of war – it’s worth reading the fine print to be sure where...
The ACTU reckons Australian workers should be consulted on every AI system rolled out in not only their workplaces (fair enough) but also in the...
Ask Peter Switzer for his best investment advice and he'll usually tell you to look for "quality stocks that have been beaten up by the...